The Aerospace Medical Association, as part of the 2021 Virtual International Conference in Aerospace Medicine (2021 Virtual ICAM), is offering a two-part webinar series titled "COVID-19 Clinical Impacts and Aeromedical Implications for Aircrew Health and Performance."

The 2021 Virtual ICAM is a series of webinars offered throughout 2021 to replace the ICAM Paris that was postponed from September 2021 to September 2022. The theme of the 2021 Virtual ICAM is "Pandemics and Progress in Aerospace Medicine."

The International Academy of Aviation and Space Medicine (IAASM) is leading the 2021 Virtual ICAM in collaboration with the Aerospace Medical Association (AsMA), the European Society of Aerospace Medicine (ESAM), and La Société Francophone de Médecine Aérospatiale (SOFRAMAS).

COVID-19 : new virus, pandemic and what is expected from vaccination
Prof. Dr. Antonio Cassone, MD

Helping People Perform to Their Best to Inspire the Recovery
Mr. John Franklin - Head of Safety Promotion EASA

In-flight Transmission of SARS-CoV-2: What We Do and Don’t Know
Dr. David O. Freedman, MD - Managing Senior Director, Shoreland Travax and Professor Emeritus of Infectious Diseases, University of Alabama at Birmingham

COVID-19 Vaccines: commercial aviation considerations
Dr. Ian Hosegood MD – Director of Medical Services Quantas, Australia

The United Kingdom (UK) left the European Union (EU) on February 1, 2020. At the time, the EU and the UK agreed on a transition period lasting until December 31, 2020, during which EU law, including EU law on aviation safety, would continue to apply to the UK. The EU and the UK have used this period to negotiate an agreement on their future partnership.

Following negotiations, the European Commission has reached, on December 24, 2020, a trade and cooperation agreement with the United Kingdom on the terms of its future cooperation with the European Union. The Trade and Cooperation Agreement is applied provisionally as of 1 January 2021.

On January 1, 2021 EU aviation safety legislation, including Regulation (EU) 2018/1139 establishing EASA, no longer applies to the UK. As of that date, the UK is considered as a third country and no longer has the status of an ‘EASA Member State’.

Until 31 December 2020, all UK-certificated AMEs, OHMPs and Aeromedical Centres (AeMCs) will continue to be able to issue medical certificates to applicants who hold or are applying for EU licences and cabin crew attestations.

From 1 January 2021, all AMEs, OHMPs and AeMCs for whom the UK is the Competent Authority, will continue to be certificated to perform medical examinations on UK applicants and issue UK PART MED medical certificates and cabin crew medical reports. UK-certificated AMEs wishing to undertake EU medical examinations will have to apply to an EASA member state for third country approval (and/or to EASA for AeMCs).

From 1 January 2021 until 31 December 2022, non-UK EU AMEs (and AeMCs) will only be ‘recognised’ by the UK if the AME (or AeMC) approval certificate was valid on or before 31 December 2020 and had not expired, been suspended or revoked when the medical examination was performed. Examinations and assessments performed by EU OHMPs will not be recognised.

From 1 January 2023 all EU AME, EU OHMP and EU AeMC approval certificates will not be valid for undertaking UK PART MED medical examinations/assessments.

For more details: https://info.caa.co.uk/

The European Society of Aerospace Medicine’s Academy presents its New Year’s online webinar on chances of recovery of the aviation industry in light of the latest aeromedical developments of the COVID-19 pandemic.

This was a lively and fruitful meeting, with discussions mainly centred at improving the communication with our member associations/societies and a...
Read more

A summary of Fly safe Fly well has been posted onto the website by our webmaster because I was having technical difficulties with my blog. These ar...
Read more